垂体后叶素治疗咯血致低钠血症的药学监护  

Pharmaceutical Care of Clinical Pharmacist Participating in the Treatment of Hemoptysis with Hyponatremia Induced by Pituitrin

作　　者：王玉 叶晓芬 柳杰[3] WANG Yu;YE Xiaofen;LIU Jie(Department of Pharmacy,the Second People's Hospital of Changzhou City,Jiangsu Province,Chang Zhou 213000,China;Department of Pharmacy,Zhongshan Hospital of Fudan University,Shanghai 200032,China;Department of Pharmacy,the First Affiliated Hospital of Dalian Medical University,Dalian 116011,China)

机构地区：[1]江苏省常州市第二人民医院药剂科,常州213000 [2]复旦大学附属中山医院药剂科,上海200032 [3]大连医科大学附属第一医院药剂科,大连116011

出　　处：《医药导报》2019年第8期1082-1084,共3页Herald of Medicine

摘　　要：目的分析垂体后叶素导致低钠血症的原因以及临床药师在治疗期间的作用。方法临床药师参与1例垂体后叶素治疗咯血的药物治疗,分析发生低钠血症的原因,协助医师调整药物治疗方案,监测血电解质浓度,避免不良后果发生。结果医师采纳临床药师建议,患者咯血症状好转,血钠水平恢复稳定。结论临床药师参与治疗方案的制订和调整,为患者的用药安全提供保障。Objective To analyze the causes of persistent hyponatremia induced by pituitrin and the role of clinical pharmacists during treatment.Methods The clinical pharmacist participated in the analysis of hyponatremia in the course of drug treatment of hemoptysis with pituitrin in 1 case,assisted the physician to adjust the drug treatment program,monitored the blood electrolyte concentration,and avoided adverse consequences.Results The physician adopted the advice of the clinical pharmacists,and the patient's hemoptysis improved,and blood sodium level returned to stability.Conclusion The participation of clinical pharmacists in the formulation and adjustment of treatment programs can guarantee the safety of patients'medications.

关 键 词：垂体后叶素 临床药师 支气管扩张 咯血 低钠血症 

分 类 号：R983.1[医药卫生—药品] R969.3[医药卫生—药学]